Lead sponsor
Neurotrope Bioscience, Inc.
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
386
Total enrollment
60
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
1
Phase 2
3
Trials by status
Completed
3
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's DiseaseAlzheimer's diseasePh 2Completed147
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On MemantineAlzheimer's diseasePh 2Completed108
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Diseaseprodromal ADPh 1/2Terminated9